FDA Seeks Guidance On Applications for Generic Drugs

The Food and Drug Administration wants to make the regulatory process for generic drugs go faster. The agency is seeking comments on its draft guidance for generic drug applications, including input about common deficiencies in abbreviated new drug applications.

YOUR COMPLIMENTARY 15-DAY LAW.COM TRIAL HAS ENDED.
Subscribe now to continue reading →

To continue reading, upgrade and become a Law.com subscriber.
Get 2 MONTHS FREE when you sign up for a 12 month subscription.